Project Number WE.03-2018-03 Agency/Funding Organization Alzheimer Nederland Funding Year 2018 View Full Project Details for In vivo epigenetic editing of Oxt in Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 17. Genetics f. Gene Editing Researcher and Organization Principal Investigator VAN DEN HOVE, Daniel L.A. Principal Investigator First Name Daniel L.A. Principal Investigator Last Name VAN DEN HOVE Awardee Organization Maastricht University Awardee State Limburg Contact PI Country The Netherlands Project Detail FY Overall Cost $200,000 Funding Organization Agency/Funding Organization Alzheimer Nederland Funding Organization Country The Netherlands Program Official van den Crommenacker, T.